Operationalizing fear of cancer recurrence care: a modified Delphi study establishing a consensus-based clinical pathway for Danish cancer survivors
DOI:
https://doi.org/10.2340/1651-226X.2026.46444Keywords:
Cancer Survivors, Neoplasms, Clinical Pathways, Delphi method, practice guideline, psycho-oncologyAbstract
Background and purpose: Fear of cancer recurrence (FCR) is a prevalent concern among cancer survivors. Although evidence-based FCR guidelines exist, their implementation requires further operationalization. This study aimed to establish expert consensus on a clinical pathway to operationalize guideline-concordant FCR care in Denmark.
Patient/material and methods: A modified Delphi study was conducted, comprising Round 0 and three Delphi rounds. In Round 1, 112 experts were invited, and 80 participated (71%) in an online survey rating proposed pathway statements. Twenty-seven participants attended a consensus workshop (Round 2) to discuss and refine statements not reaching consensus in Round 1. In Round 3, 71 participants (63%) re-rated the revised statements from Round 2. Consensus was defined as ≥ 80% agreement.
Results: Consensus was achieved for 10 statements in Round 1 and 6 revised or newly formulated statements in Round 3, including systematic screening of all cancer survivors with validated tools using a two-step approach, and initiation of screening at transition from treatment to follow-up. Consensus was achieved for need-based assessment guided by symptom severity and patient-expressed need. A matched-care model, aligning treatment intensity with FCR severity, achieved consensus in Round 1. Ongoing monitoring through re-screening during follow-up and post-intervention was endorsed. Timing of assessment and the management of FCR treatment non-response did not reach consensus.
Interpretation: This Delphi study provides a consensus-based clinical pathway for FCR, including systematic screening, needs-based assessment, and matched-care allocation. The findings address key implementation gaps in existing FCR guidelines and offer a structured framework for integrating FCR care into routine practice.
Downloads
References
Lebel S, Ozakinci G, Humphris G, Mutsaers B, Thewes B, Prins J. From normal response to clinical problem: definition and clinical features of fear of cancer recurrence. Support Care Cancer. 2016;24(8):3265–8. DOI: https://doi.org/10.1007/s00520-016-3272-5
Luigjes-Huizer YL, Tauber NM, Humphris G, Kasparian NA, Lam WWT, Lebel S. What is the prevalence of fear of cancer recurrence in cancer survivors and patients? A systematic review and individual participant data meta-analysis. Psychooncology. 2022;31(6):879–92. DOI: https://doi.org/10.1002/pon.5921
Lisy K, Langdon L, Piper A, Jefford M. Identifying the most prevalent unmet needs of cancer survivors in Australia: a systematic review. Asia-Pacific J Clin Oncol. 2019;15(5):e68–78. DOI: https://doi.org/10.1111/ajco.13176
Simard S, Thewes B, Humphris G, Dixon M, Hayden C, Mireskandari S, et al. Fear of cancer recurrence in adult cancer survivors: a systematic review of quantitative studies. J Cancer Surviv. 2013;7(3):300–22. DOI: https://doi.org/10.1007/s11764-013-0272-z
Lyhne JD, Jensen LH, Fink P, Timm S, Frostholm L, Smith A. Fear of cancer recurrence in long-term colorectal cancer survivors: a nationwide cross-sectional study. J Cancer Surviv. 2025;20:1431-42. DOI: https://doi.org/10.1007/s11764-025-01746-z
Williams JTW, Pearce A, Smith A. A systematic review of fear of cancer recurrence related healthcare use and intervention cost-effectiveness. Psychooncology. 2021;30(8):1185–95. DOI: https://doi.org/10.1002/pon.5673
Vandraas K, Reinertsen KV, Smedsland S, Bøhn S, Kiserud C, Falk RS, et al. Fear of cancer recurrence eight years after early-stage breast cancer – results from a national survey. Acta Oncol. 2023;62(6):635–41. DOI: https://doi.org/10.1080/0284186X.2023.2224052
Shaw J, Kamphuis H, Sharpe L, Lebel S, Smith AB, Hulbert-Williams N, et al. Setting an international research agenda for fear of cancer recurrence: an online Delphi consensus study. Front Psychol. 2021;12:596682. DOI: https://doi.org/10.3389/fpsyg.2021.596682
Rudy L, Maheu C, Körner A, Lebel S, Gélinas C. The FCR-1: initial validation of a single-item measure of fear of cancer recurrence. Psychooncology. 2020;29(4):788–95. DOI: https://doi.org/10.1002/pon.5350
Smith AB, Gao M, Tran M, Ftanou M, Jegathees S, Wu V, et al. Evaluation of the validity and screening performance of a revised single‐item fear of cancer recurrence screening measure (FCR‐1r). Psychooncology. 2023 Jun;32(6):961-71. DOI: https://doi.org/10.1002/pon.6139
Lyhne JD, Smith AB, Timm S, Simard S, Jensen LH, Frostholm L, et al. Validity and screening capacity of the FCR-1r for fear of cancer recurrence in long-term colorectal cancer survivors. Support Care Cancer. 2023;31(12):690. DOI: https://doi.org/10.1007/s00520-023-08159-7
Thewes B, Butow P, Zachariae R, Christensen S, Simard S, Gotay C. Fear of cancer recurrence: a systematic literature review of self-report measures. Psycho-oncology. 2012;21(6):571–87. DOI: https://doi.org/10.1002/pon.2070
Tauber NM, O’Toole MS, Dinkel A, Galica J, Humphris G, Lebel S, et al. Effect of psychological intervention on fear of cancer recurrence: a systematic review and meta-analysis. J Clin Oncol. 2019;37(31):2899–915. DOI: https://doi.org/10.1200/JCO.19.00572
Lebel CZS, Craig L, Conrod R, Freeman L, Galica J, Maheu C, et al. Fear of Cancer recurrence guideline 2024. [cited 2024 Oct 8]. Available from: https://www.cancercareontario.ca/en/guidelines-advice/.
DMCG. Angst, depression og frygt for tilbagefald af kræft 2025. [cited 2025 Aug 22]. Available from: https://www.dmcg.dk/siteassets/kliniske-retningslinjer/opdelt-paa-dmcg/tvargaende-retningslinjer/tvarg_rl_angst_depr_v1.0_admgodk220825.pdf
Smith AB, Girgis A, Taylor N, Pearce A, Liu J, Shepherd HL, et al. Step-by-step: a clinical pathway for stepped care management of fear of cancer recurrence – results of a three-round online delphi consensus process with Australian health professionals and researchers. J Cancer Survivor. 2024;20:766-80. DOI: https://doi.org/10.1007/s11764-024-01685-1
Fitch K, Bernstein SJ, Aguilar MD, Burnand B, LaCalle JR. The RAND/UCLA appropriateness method user’s manual. RAND. Santa Monica, California. 2001.
Shaw JM, Price MA, Clayton JM, Grimison P, Shaw T, Rankin N, et al. Developing a clinical pathway for the identification and management of anxiety and depression in adult cancer patients: an online Delphi consensus process. Support Care Cancer. 2016;24(1):33–41. DOI: https://doi.org/10.1007/s00520-015-2742-5
Jünger S, Payne SA, Brine J, Radbruch L, Brearley SG. Guidance on Conducting and REporting DElphi Studies (CREDES) in palliative care: recommendations based on a methodological systematic review. Palliat Med. 2017;31(8):684–706. DOI: https://doi.org/10.1177/0269216317690685
Brouwers MC, Kho ME, Browman GP, Burgers JS, Cluzeau F, Feder G, et al. Development of the AGREE II, part 1: performance, usefulness and areas for improvement. CMAJ. 2010;182(10):1045–52. DOI: https://doi.org/10.1503/cmaj.091714
Brouwers MC, Kho ME, Browman GP, Burgers JS, Cluzeau F, Feder G, et al. Development of the AGREE II, part 2: assessment of validity of items and tools to support application. CMAJ. 2010;182(10):E472–8. DOI: https://doi.org/10.1503/cmaj.091716
Phillips B, Ball C, Badenoch D, Straus S, Haynes B, Dawes M. Oxford centre for evidence-based medicine levels of evidence (May 2001). BJU Int. 2011;107(5):870. DOI: https://doi.org/10.1111/j.1464-410X.2011.10141.x
Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap) – a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377–81. DOI: https://doi.org/10.1016/j.jbi.2008.08.010
Harris PA, Taylor R, Minor BL, Elliott V, Fernandez M, O’Neal L, et al. The REDCap consortium: building an international community of software platform partners. J Biomed Inform. 2019;95:103208. DOI: https://doi.org/10.1016/j.jbi.2019.103208
Simard S, Savard J. Fear of Cancer Recurrence Inventory: development and initial validation of a multidimensional measure of fear of cancer recurrence. Support Care Cancer. 2009;17(3):241–51. DOI: https://doi.org/10.1007/s00520-008-0444-y
Liu JJ, Butow P, Beith J. Systematic review of interventions by non-mental health specialists for managing fear of cancer recurrence in adult cancer survivors. Support Care Cancer. 2019;27(11):4055–67. DOI: https://doi.org/10.1007/s00520-019-04979-8
Mutsaers B, Butow P, Dinkel A, Humphris G, Maheu C, Ozakinci G. Identifying the key characteristics of clinical fear of cancer recurrence: an international Delphi study. Psycho-oncology. 2020;29(2):430–6. DOI: https://doi.org/10.1002/pon.5283
Luigjes-Huizer YL, van der Lee ML, Richel C, Masselink RA, de Wit NJ, Helsper CW. Patient-reported needs for coping with worry or fear about cancer recurrence and the extent to which they are being met: a survey study. J Cancer Survivor. 2024;18(3):791–9. DOI: https://doi.org/10.1007/s11764-022-01326-5
Sundhedsministeriet I-O. Et bedre liv med og efter kræft – Kræftplan V. 2025 [cited 2026 Jan 10]. Available from: https://www.ism.dk/publikationer-sundhed/2025/maj/et-bedfre-liv-med-og-efter-kraeft
Abdalla T, Singh GK, Pourali Roudbaneh S, Serwaa D, Peate M. Stepped-care models for cancer symptom management: a systematic review of efficacy and cost-effectiveness. J Natl Cancer Inst. 2026;118(1):26–48. DOI: https://doi.org/10.1093/jnci/djaf153
Tremblay D, Touati N, Bilodeau K, Prady C, Usher S, Leblanc Y. Risk-stratified pathways for cancer survivorship care: insights from a deliberative multi-stakeholder consultation. Curr Oncol (Toronto, Ont). 2021;28(5):3408–19. DOI: https://doi.org/10.3390/curroncol28050295
Andersen BL, Lacchetti C, Ashing K, Berek JS, Berman BS, Bolte S, et al. Management of anxiety and depression in adult survivors of cancer: ASCO guideline update. J Clin Oncol. 2023;41(18):3426–53. DOI: https://doi.org/10.1200/JCO.23.00293
Pradhan P, Sharpe L, Menzies RE. Towards a stepped care model for managing fear of cancer recurrence or progression in cancer survivors. Cancer Manag Res. 2021;13:8953–65. DOI: https://doi.org/10.2147/CMAR.S294114
Lynch FA, Katona L, Jefford M, Smith AB, Shaw J, Dhillon HM, et al. Feasibility and acceptability of fear-less: a stepped-care program to manage fear of cancer recurrence in people with metastatic melanoma. J Clin Med. 2020;9(9):2969. DOI: https://doi.org/10.3390/jcm9092969
Kolsteren EEM, Deuning-Smit E, Chu AK, van der Hoeven YCW, Prins JB, van der Graaf WTA, et al. Psychosocial aspects of living long term with advanced cancer and ongoing systemic treatment: a scoping review. Cancers. 2022 Aug 11;14(16):3889. DOI: https://doi.org/10.3390/cancers14163889
Ministero della Salute. Piano Oncologico Nazionale: documento di pianificazione e indirizzo per la prevenzione e il contrasto del cancro 2023–2027. Rome, Italy (Roma): Ministero della Salute; 2023.
Downloads
Additional Files
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2026 Johanne Dam Lyhne, Pernille Bech , Eva Rames Nissen , Christina Maar Andersen , Anne Katrine Hartmann Søby, Brigitta R Villumsen, Henriette Vind Thaysen, Laura Sandholdt Jensen, Iben Husted Nielsen , Thea Otto Mattsson, Anne Johansen , Emma Skov Rahbæk, Ulrike Johansen , Frederik Lynge Overgaard, Lise Ventzel , Lars Henrik Jensen , Matteo Allegretti, Eriseld Krasniqi, Allan 'Ben' Smith, Anders Bonde Jensen
This work is licensed under a Creative Commons Attribution 4.0 International License.
